| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |